Documentation and data integrity deficiencies appeared in 21% of FDA CGMP warning letters analyzed from 2010 to 2020. Therefore, pharmaceutical teams need stronger control over approved procedures, changes, records, and inspection evidence. A pharma document management system can support this control by keeping regulated information traceable and accessible. Moreover, as digitalization in pharma industry expands, effective document governance becomes increasingly important for GMP compliance and inspection readiness.
Table of Contents
What Is a Pharma Document Management System in GMP
A pharmaceutical document management system controls GMP documents throughout their full lifecycle. It manages drafting, review, approval, distribution, revision, retrieval, retention, and retirement. Therefore, teams can identify the current approved version and reduce uncontrolled document use. Moreover, strong lifecycle controls help QA teams maintain traceability and reliable records. In the pharmaceutical industry, effective document management also makes critical evidence easier to retrieve during audits and inspections.
This infographic shows the GMP document lifecycle from drafting through retirement, helping teams understand where control and traceability must be maintained.
Why Document Control Matters for GMP Compliance?
GMP document control helps pharmaceutical teams prove that employees follow current, approved instructions. It also keeps regulated activities traceable and easier to review. Therefore, strong controls reduce the risk of outdated procedures, missing approvals, and uncontrolled copies. Moreover, clear document histories help QA teams respond faster during audits and inspections. Effective control supports both daily compliance and reliable inspection evidence.
Four Document Controls That Support Inspection Readiness
Strong document controls help pharmaceutical teams maintain reliable GMP records throughout their lifecycle. They also make approvals, changes, access, and retention easier to trace. Therefore, inspectors can verify how documents were created, updated, and controlled. Moreover, clear evidence reduces uncertainty during audits and supports stronger inspection readiness.
The following four controls show how pharmaceutical teams can keep GMP documents accurate, traceable, secure, and ready for inspection.
- Controlled Authoring, Review, and Approval (PDF)
- Version Control and Controlled Change (PDF)
- Audit Trails, Access Control, and Electronic Signatures (PDF)
- Retention, Retrieval, and Data Integrity (PDF)
Controlled Authoring, Review, and Approval (PDF)
Controlled authoring ensures GMP documents are clear, accurate, and properly identified. Formal review and approval confirm authorized release before operational use.
Version Control and Controlled Change (PDF)
Version control helps teams identify current documents and trace revisions. Controlled change procedures also reduce the risk of unapproved updates affecting GMP activities.
Audit Trails, Access Control, and Electronic Signatures (PDF)
Audit trails record key electronic actions, while access controls limit system use to authorized personnel. Electronic signatures also link regulated actions to accountable individuals.
Retention, Retrieval, and Data Integrity (PDF)
Strong retention controls keep GMP records complete, secure, and available throughout their lifecycle. Reliable retrieval also helps teams reconstruct regulated activities during audits and inspections.
How Inspectors Test an Electronic Document Management System
Inspectors often test whether an electronic document system can produce reliable evidence quickly. They may review approvals, revision histories, user permissions, electronic records, and documented changes. Therefore, teams must keep records complete, traceable, and easy to retrieve. Moreover, clear system controls help QA teams respond confidently during GMP inspections.
This infographic shows the key electronic document controls inspectors may test and why each control supports reliable GMP evidence.
How to Evaluate a GMP Document Management System
QA teams should evaluate a GMP document management system by checking the controls that protect regulated records. The system should keep documents current, traceable, secure, and available throughout their lifecycle. Moreover, teams should verify how it controls changes, access, approvals, and electronic records. Therefore, the evaluation should focus on inspection evidence rather than convenience alone.
The table below shows the key controls QA teams should verify and the inspection risks that weak controls may create.
| Control Area | Evidence to Verify | Regulatory Expectation | Inspection Risk if Weak |
|---|---|---|---|
|
Document Approval |
Approved document, authorized reviewer, signature, approval date, effective date |
Release controlled documents only after appropriate review and approval. |
Staff may use unapproved or incomplete instructions. |
|
Version Control |
Current version, revision history, superseded versions, revision dates |
Keep documents current and control revisions throughout their lifecycle. |
Teams may follow conflicting or obsolete instructions. |
|
Audit Trails |
Change history, user identity, timestamps, reasons for changes |
Record GMP-relevant changes and keep audit trails available for review. |
Teams may struggle to reconstruct who changed critical information and why. |
|
User Access |
User roles, permissions, access records, authorization changes |
Restrict system access to authorized users based on defined responsibilities. |
Unauthorized users may create, modify, or approve GMP records. |
Final Words
In 2024–2025, the MHRA conducted 353 GMP inspections, highlighting sustained regulatory attention to pharmaceutical compliance. As oversight continues, a pharma document management system should do more than store files. It should help teams retrieve current records, trace changes, and demonstrate clear approval histories. Therefore, strong document control remains essential for inspection readiness.
Digital Solutions for GMP Operations
We support pharmaceutical teams in implementing, maintaining, and optimizing GMP software, data management systems, and computerized workflows that strengthen compliance, data integrity, and operational efficiency.
FAQ
It should record who performed an action, what changed, when it changed, and why when applicable. The audit trail should also support reconstruction of regulated electronic record activity.
QA should control document versions, withdraw superseded copies, and ensure only current approved versions remain available for use. Clear revision histories should also show what changed and when.
Required electronic records should remain complete, accurate, readable, and readily accessible throughout their retention period. Firms should also retain associated metadata and relevant audit-trail information needed to reconstruct regulated activities.
References
Reza Esmaeili is a technology and product leader in Germany, combining CTO and CPO experience to bridge engineering execution with customer-driven product strategy. He has led cloud and automation initiatives that improved operational efficiency and reduced costs. He has managed cross-functional teams of engineers and product managers and brought new software products from concept to market. He focuses on building data-driven product organizations by introducing analytics to track performance and guide decisions. He champions Agile ways of working to shorten feedback loops, improve quality, and accelerate go-to-market execution in close partnership with sales and marketing.